Pierre-Jean Ripoll

BioProtein Technologies SA develops recombinant therapeutic proteins and vaccines. Its proprietary technology offers customized packages supplying highly purified biopharmaceuticals. The firm provides pharmaceutical and biotechnology companies with integrated services from gene expression to industrial production of proteins and vaccines in milk. The company was founded on July 1, 1988 by Marc Le Bozec, Louis-Marie Houdebine, Jean-Paul Renard, Bernard Jégou and François Deneux and is headquartered in Jouy-en-Josas, France.

Biogemma SA provides commercial, physical, and biological research and development. The firm carries out biotechnology research on field crops. It develops genomic approaches which include gene candidates, expression, and germplasm interaction. The company was founded in 1997 and is headquartered in Chappes, France.